[{"Assets_0_Q2_USD":274846000.0,"CommonStockSharesOutstanding_0_Q2_shares":36680522.0,"EarningsPerShareBasic_1_Q2_USD":-1.14,"EarningsPerShareBasic_2_Q2_USD":-2.21,"EarningsPerShareDiluted_1_Q2_USD":-1.14,"EarningsPerShareDiluted_2_Q2_USD":-2.21,"NetIncomeLoss_1_Q2_USD":-40654000.0,"NetIncomeLoss_2_Q2_USD":-78310000.0,"StockholdersEquity_0_Q2_USD":231348000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":35784804.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":35373799.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":35784804.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":35373799.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]